158 related articles for article (PubMed ID: 6100760)
1. Placental protein 5 (PP5): biological and clinical studies.
Salem HT; Chard T
Placenta Suppl; 1982; 4():103-14. PubMed ID: 6100760
[No Abstract] [Full Text] [Related]
2. New placental proteins in placental dysfunction.
Lee JN; Chard T
Contrib Gynecol Obstet; 1982; 9():157-69. PubMed ID: 6183052
[No Abstract] [Full Text] [Related]
3. Maternal serum levels of placental protein 5 in complications of late pregnancy.
Salem HT; Westergaard JG; Hindersson P; Lee JN; Grudzinskas JG; Chard T
Obstet Gynecol; 1982 Apr; 59(4):467-71. PubMed ID: 7078900
[TBL] [Abstract][Full Text] [Related]
4. Placental protein 5 (PP5) in complicated pregnancies.
Nisbet AD; Bremner RD; Jandial V; Sutherland HW; Horne CW; Bohn H
Br J Obstet Gynaecol; 1981 May; 88(5):492-9. PubMed ID: 7236552
[TBL] [Abstract][Full Text] [Related]
5. [Pregnancy specific beta-1-glycoprotein].
Seppälä M; Rutanen EM
Duodecim; 1979; 95(22):1490-8. PubMed ID: 230953
[No Abstract] [Full Text] [Related]
6. [Do pregnancy proteins have prospective significance? (SP-1, HPL and PP-5)].
Tatra G; Lüben G; Nasr F
Geburtshilfe Frauenheilkd; 1985 Jun; 45(6):363-6. PubMed ID: 3874806
[TBL] [Abstract][Full Text] [Related]
7. Clinical applications of pregnancy protein estimations with particular reference to pregnancy-associated plasma protein A (PAPP-A).
Stabile I; Grudzinskas JG; Chard T
Obstet Gynecol Surv; 1988 Feb; 43(2):73-82. PubMed ID: 2448714
[No Abstract] [Full Text] [Related]
8. A study on the serum pregnancy zone protein levels in pregnant women and patients with gynecological tumors.
Teng H; Zhang WY; Zhu FQ
Chin Med J (Engl); 1994 Dec; 107(12):910-4. PubMed ID: 7882729
[TBL] [Abstract][Full Text] [Related]
9. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
Dugoff L; Hobbins JC; Malone FD; Porter TF; Luthy D; Comstock CH; Hankins G; Berkowitz RL; Merkatz I; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Vidaver J; D'Alton ME
Am J Obstet Gynecol; 2004 Oct; 191(4):1446-51. PubMed ID: 15507981
[TBL] [Abstract][Full Text] [Related]
10. The effect of protamine on serum levels of placental protein 5 (PP5) in normal and abnormal pregnancy: a possible relation to coagulation abnormalities.
Salem HT; Seppälä M; Ranta T; Bohn H; Chard T
Br J Obstet Gynaecol; 1981 Apr; 88(4):367-70. PubMed ID: 7225294
[TBL] [Abstract][Full Text] [Related]
11. Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts.
Udagawa K; Yasumitsu H; Esaki M; Sawada H; Nagashima Y; Aoki I; Jin M; Miyagi E; Nakazawa T; Hirahara F; Miyazaki K; Miyagi Y
Placenta; 2002; 23(2-3):145-53. PubMed ID: 11945080
[TBL] [Abstract][Full Text] [Related]
12. Alpha-fetoprotein.
Seppälä M; Ruoslahti E
Contrib Gynecol Obstet; 1976; 2():143-86. PubMed ID: 77205
[No Abstract] [Full Text] [Related]
13. Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies.
Burger O; Pick E; Zwickel J; Klayman M; Meiri H; Slotky R; Mandel S; Rabinovitch L; Paltieli Y; Admon A; Gonen R
Placenta; 2004 Aug; 25(7):608-22. PubMed ID: 15193867
[TBL] [Abstract][Full Text] [Related]
14. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of pregnancy-specific beta 1-glycoprotein analysis in endocrine tests of the gonadal and placental system].
Mochizuki M
Nihon Rinsho; 1989 Dec; 48 Suppl():1274-8. PubMed ID: 2560074
[No Abstract] [Full Text] [Related]
16. Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key.
Ogawa M; Yanoma S; Nagashima Y; Okamoto N; Ishikawa H; Haruki A; Miyagi E; Takahashi T; Hirahara F; Miyagi Y
Placenta; 2007; 28(2-3):224-32. PubMed ID: 16580726
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of b-human chorionic gonadotropin and human placental lactogen between 11-13 weeks' gestation and subsequent pregnancy complications in Omani women.
Krolikowski A; Al Busaidi F; Al Wahaibi A
Saudi Med J; 2004 Mar; 25(3):382-4. PubMed ID: 15048184
[No Abstract] [Full Text] [Related]
18. [Hormonal profiles during the first trimester in pathological pregnancies].
Oury JF; Chartier M; Barrat J; Roger M; Scholler R
Pathol Biol (Paris); 1980 Jun; 28(6):390. PubMed ID: 6994051
[No Abstract] [Full Text] [Related]
19. The new placental proteins (some observations on their clinical significance).
Klopper A
Ric Clin Lab; 1982; 12(1):241-9. PubMed ID: 6178144
[No Abstract] [Full Text] [Related]
20. Antithrombin III in late pregnancy.
Hellgren M; Nygårds EB; Robbe H
Acta Obstet Gynecol Scand; 1982; 61(2):187-9. PubMed ID: 7113696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
